# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA624712 | F | Compound was tested for cytotoxicity against A-549 human solid tumor cell line | Homo sapiens | 3 | ALA1134739 | cell-based format | Scientific Literature | |
2. | ALA657428 | F | Compound was tested for cytotoxicity against CaOv3 human solid tumor cell line | Homo sapiens | 1 | ALA1134739 | cell-based format | Scientific Literature | |
3. | ALA661491 | B | Compound was tested for its binding affinity towards calf thymus DNA | Bos taurus | 5 | ALA1134739 | nucleic acid format | Scientific Literature | |
4. | ALA880040 | F | Compound was tested for cytotoxicity against HT-29 human solid tumor cell line | Homo sapiens | 3 | ALA1134739 | cell-based format | Scientific Literature | |
5. | ALA699651 | F | The cytotoxic activity was determined against KB cell line. | Mus musculus | 3 | ALA1122150 | cell-based format | Scientific Literature | |
6. | ALA704121 | F | Cytotoxicity against murine lymphoblastic leukemia cells (L1210). | Mus musculus | 17 | ALA1126908 | cell-based format | Scientific Literature | |
7. | ALA709132 | F | Compound was tested for cytotoxicity against MCF-7 human solid tumor cell line | Homo sapiens | 2 | ALA1134739 | cell-based format | Scientific Literature | |
8. | ALA754538 | F | Cytotoxicity was measured on murine leukemia p388 | Mus musculus | 2 | ALA1126908 | cell-based format | Scientific Literature | |
9. | ALA754539 | F | Cytotoxicity was measured on murine leukemia p388 CPT 0.3 | Mus musculus | 2 | ALA1126908 | cell-based format | Scientific Literature | |
10. | ALA754544 | F | Cytotoxicity was measured on murine leukemia p388 | Mus musculus | 2 | ALA1126908 | cell-based format | Scientific Literature | |
11. | ALA754545 | F | Cytotoxicity was measured on murine leukemia p388 CPT 0.3 | Mus musculus | 2 | ALA1126908 | cell-based format | Scientific Literature | |
12. | ALA755750 | F | Evaluated for percentage test/control (%T/C) in survival tumor system against P388 lymphocytic leukemia | Mus musculus | 2 | ALA1122789 | cell-based format | Scientific Literature | |
13. | ALA756330 | F | Percentage of treated /control was determined against P-388 leukemia in BDG1 mice, at a dose of 320 mg/kg | Mus musculus | 1 | ALA1122150 | organism-based format | Scientific Literature | |
14. | ALA822983 | B | Compound was tested for its binding affinity towards poly(AT) | 5 | ALA1134739 | nucleic acid format | Scientific Literature | ||
15. | ALA822984 | B | Compound was tested for its binding affinity towards poly(GC) | 5 | ALA1134739 | nucleic acid format | Scientific Literature | ||
16. | ALA849380 | F | The ratio of the mean survival time of treated animals on the mean survival time of controls multiplied by 100.It is measured at dose of 100 mg/kg; T/C value | 1 | ALA1126908 | organism-based format | Scientific Literature | ||
17. | ALA941104 | B | Inhibition of HIV1 reverse transcriptase | Human immunodeficiency virus 1 | 8 | ALA1149052 | single protein format | Scientific Literature | |
18. | ALA955283 | F | Cytotoxicity against human KB cells | Homo sapiens | 27 | ALA1148992 | cell-based format | Scientific Literature | |
19. | ALA955284 | F | In vivo cytotoxicity against mouse P388 cells relative to control | Mus musculus | 4 | ALA1148992 | organism-based format | Scientific Literature | |
20. | ALA984056 | B | Inhibition of DNA dependent DNA polymerase activity of HIV1 recombinant reverse transcriptase p66/p51 | Human immunodeficiency virus 1 | 5 | ALA1158280 | assay format | Scientific Literature |